Schedule 13G ownership disclosure

RIGEL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 766559603

Event date: 2017-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
20,295,036
Percent of class
13.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-18-000376
Form type
SC 13G/A
Filer
RIGEL PHARMACEUTICALS INC
CIK
CIK 1034842
Filed
Feb 08, 2018
Reporting period
Dec 29, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub